A Major Drug Company Now Has Access to 23andMe’s Genetic Data. Should You Be Concerned ?

26 July 2018, Time

Consumer genetic testing company 23andMe announced on Wednesday that GlaxoSmithKline purchased a $300 million stake in the company, allowing the pharmaceutical giant to…Read more >>>